Journal of Pharmacovigilance and Quality Assurance ISSN: 3108-2343 (Online)

Authors: Dr. Suman Verma, Mr. Anil Patel

ABSTRACT: Reporting and monitoring adverse drug reactions (ADRs) in developing countries present unique challenges due to limited healthcare infrastructure, lack of awareness, underreporting, and inconsistent regulatory frameworks. This paper examines the key barriers to effective pharmacovigilance in developing regions, including socio-economic, cultural, and technological factors. Current methods for ADR detection, strategies to enhance reporting, and potential interventions are discussed. Tables summarizing challenges, impacts, and solutions are included. Addressing these issues is critical to improve patient safety, ensure rational drug use, and strengthen national and global pharmacovigilance efforts.

KEYWORDS: Adverse Drug Reactions, Pharmacovigilance, Developing Countries, Underreporting, Drug Safety, Regulatory Challenges